OBJECTIVE: To evaluate factors associated with self-reported generic, chronic-generic, and condition-specific quality of life (QoL) impairments in intensively treated patients with early-onset and long-duration type 1 diabetes. STUDY DESIGN: A total of 840 11- to 21-year-olds with type 1 diabetes onset before 5 years of age and at least 10 years diabetes duration completed questionnaires including the generic Revised Children's Quality of Life Questionnaire (KINDL-R), the DISABKIDS chronic-generic module (DCGM-12), and the DISABKIDS diabetes-specific module with impact and treatment scales to assess QoL. Regression analyses were conducted using sociodemographic, health-related, and diabetes-related independent variables. RESULTS: The strongest associations were observed between QoL scores and diabetes-specific factors, especially glycemic control and treatment satisfaction. The adjusted mean differences [regression coefficients β (standard error)] between patient groups with high risk vs. optimal glycemic control were β = -4.6 (1.1) for the KINDL-R total score, β = -8.6 (1.5) for the DCGM-12, β = -14.4 (1.9) for the diabetes impact score, and β = -21.1 (2.7) for the diabetes treatment score (all p < 0.001). The mean differences between patient groups with poor vs. very good treatment satisfaction were β = -5.9 (1.3) for the KINDL-R total score, β = -8.5 (1.7) for the DCGM-12, β = -9.4 (2.0) for the diabetes impact score, and β = -15.0 (2.9) for the diabetes treatment score (all p < 0.001). In addition, recent severe hypoglycemia and an insulin regimen without an insulin pump were negatively associated with the QoL scores. CONCLUSION: Good glycemic control and a high level of treatment satisfaction are associated with a positive QoL in youths with early-onset type 1 diabetes.
OBJECTIVE: To evaluate factors associated with self-reported generic, chronic-generic, and condition-specific quality of life (QoL) impairments in intensively treated patients with early-onset and long-duration type 1 diabetes. STUDY DESIGN: A total of 840 11- to 21-year-olds with type 1 diabetes onset before 5 years of age and at least 10 years diabetes duration completed questionnaires including the generic Revised Children's Quality of Life Questionnaire (KINDL-R), the DISABKIDS chronic-generic module (DCGM-12), and the DISABKIDS diabetes-specific module with impact and treatment scales to assess QoL. Regression analyses were conducted using sociodemographic, health-related, and diabetes-related independent variables. RESULTS: The strongest associations were observed between QoL scores and diabetes-specific factors, especially glycemic control and treatment satisfaction. The adjusted mean differences [regression coefficients β (standard error)] between patient groups with high risk vs. optimal glycemic control were β = -4.6 (1.1) for the KINDL-R total score, β = -8.6 (1.5) for the DCGM-12, β = -14.4 (1.9) for the diabetes impact score, and β = -21.1 (2.7) for the diabetes treatment score (all p < 0.001). The mean differences between patient groups with poor vs. very good treatment satisfaction were β = -5.9 (1.3) for the KINDL-R total score, β = -8.5 (1.7) for the DCGM-12, β = -9.4 (2.0) for the diabetes impact score, and β = -15.0 (2.9) for the diabetes treatment score (all p < 0.001). In addition, recent severe hypoglycemia and an insulin regimen without an insulin pump were negatively associated with the QoL scores. CONCLUSION: Good glycemic control and a high level of treatment satisfaction are associated with a positive QoL in youths with early-onset type 1 diabetes.
Authors: Christina Bächle; Anna Peneva; Werner Maier; Katty Castillo; Anna Stahl-Pehe; Oliver Kuß; Rolf Holle; Julia M Hermann; Reinhard W Holl; Joachim Rosenbauer Journal: Qual Life Res Date: 2018-08-11 Impact factor: 4.147
Authors: Clara Y Ye; Thor C Jeppson; Ellen M Kleinmaus; Harald M Kliems; Jennifer M Schopp; Elizabeth D Cox Journal: Diabetes Educ Date: 2017-03-21 Impact factor: 2.140
Authors: Dayna E McGill; Lisa K Volkening; David M Pober; Andrew B Muir; Deborah L Young-Hyman; Lori M Laffel Journal: J Adolesc Health Date: 2017-12-06 Impact factor: 5.012
Authors: Anna Stahl-Pehe; Karin Lange; Christina Bächle; Katty Castillo; Reinhard W Holl; Joachim Rosenbauer Journal: PLoS One Date: 2014-03-17 Impact factor: 3.240
Authors: Kathrin I Fischer; Felix H Fischer; Dana Barthel; Christiane Otto; Ute Thyen; Marcus Klein; Otto Walter; Ulrike Ravens-Sieberer; Matthias Rose; Sandra Nolte Journal: Front Pediatr Date: 2020-01-21 Impact factor: 3.418